{"id":"https://openalex.org/W7220207385","doi":null,"title":"Clinical outcomes of hydroxyurea therapy in the management of sickle cell disease in a tertiary health facility in Southern Nigeria","display_name":"Clinical outcomes of hydroxyurea therapy in the management of sickle cell disease in a tertiary health facility in Southern Nigeria","publication_year":2024,"publication_date":"2024-05-16","ids":{"openalex":"https://openalex.org/W7220207385"},"language":"en","primary_location":{"id":"pmh:oai:ajol.info:article/270554","doi":null,"is_oa":false,"landing_page_url":"https://www.ajol.info/index.php/jophas/article/download/270554/255357","pdf_url":null,"source":{"id":"https://openalex.org/S2764417862","display_name":"Journal of Pharmaceutical and Allied Sciences","issn_l":"1596-8499","issn":["1596-8499"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310321518","host_organization_name":"African Journals OnLine","host_organization_lineage":["https://openalex.org/P4310321518"],"host_organization_lineage_names":["African Journals OnLine"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"1596-8499","raw_type":"info:eu-repo/semantics/article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5157052530","display_name":"P.T. Osahon","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Osahon, P.T.","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5157071578","display_name":"E.A. Urom","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Urom, E.A.","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10554","display_name":"Hemoglobinopathies and Related Disorders","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10554","display_name":"Hemoglobinopathies and Related Disorders","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11660","display_name":"Blood groups and transfusion","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11280","display_name":"Hemophilia Treatment and Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hydroxyurea","display_name":"hydroxyurea","score":0.972000002861023},{"id":"https://openalex.org/keywords/sickle-cell-disease","display_name":"sickle cell disease","score":1.0},{"id":"https://openalex.org/keywords/vaso-occlusive-crisis","display_name":"vaso-occlusive crisis","score":0.8489999771118164},{"id":"https://openalex.org/keywords/blood-transfusion","display_name":"blood transfusion","score":0.8970000147819519},{"id":"https://openalex.org/keywords/hospitalization","display_name":"hospitalization","score":0.9760000109672546},{"id":"https://openalex.org/keywords/patient-reported-outcomes","display_name":"patient-reported outcomes","score":0.5630000233650208},{"id":"https://openalex.org/keywords/drug-effectiveness","display_name":"drug effectiveness","score":0.6499999761581421},{"id":"https://openalex.org/keywords/southern-nigeria","display_name":"Southern Nigeria","score":0.5329999923706055}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9099000096321106},{"id":"https://openalex.org/C2779316324","wikidata":"https://www.wikidata.org/wiki/Q212272","display_name":"Hydroxycarbamide","level":3,"score":0.6766999959945679},{"id":"https://openalex.org/C2779668550","wikidata":"https://www.wikidata.org/wiki/Q1642147","display_name":"Hemoglobinopathy","level":3,"score":0.6276999711990356},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.6229000091552734},{"id":"https://openalex.org/C2780014101","wikidata":"https://www.wikidata.org/wiki/Q183605","display_name":"Blood transfusion","level":2,"score":0.5163999795913696},{"id":"https://openalex.org/C2778620579","wikidata":"https://www.wikidata.org/wiki/Q185034","display_name":"Sickle cell anemia","level":3,"score":0.4260999858379364},{"id":"https://openalex.org/C2778248108","wikidata":"https://www.wikidata.org/wiki/Q5445","display_name":"Anemia","level":2,"score":0.421999990940094},{"id":"https://openalex.org/C2778917026","wikidata":"https://www.wikidata.org/wiki/Q43041","display_name":"Hemoglobin","level":2,"score":0.4066999852657318},{"id":"https://openalex.org/C2778488018","wikidata":"https://www.wikidata.org/wiki/Q42395","display_name":"White blood cell","level":2,"score":0.40059998631477356},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.3926999866962433},{"id":"https://openalex.org/C2780976302","wikidata":"https://www.wikidata.org/wiki/Q4677915","display_name":"Acute chest syndrome","level":4,"score":0.37310001254081726},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.35839998722076416},{"id":"https://openalex.org/C2776317666","wikidata":"https://www.wikidata.org/wiki/Q2496436","display_name":"Fetal hemoglobin","level":4,"score":0.3555000126361847},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.3434000015258789},{"id":"https://openalex.org/C2779817106","wikidata":"https://www.wikidata.org/wiki/Q7834210","display_name":"Transfusion therapy","level":3,"score":0.33980000019073486},{"id":"https://openalex.org/C104863432","wikidata":"https://www.wikidata.org/wiki/Q614304","display_name":"Pharmacy","level":2,"score":0.3107999861240387},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.28369998931884766},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.27869999408721924},{"id":"https://openalex.org/C194828623","wikidata":"https://www.wikidata.org/wiki/Q2861470","display_name":"Emergency medicine","level":1,"score":0.2784999907016754},{"id":"https://openalex.org/C2779951463","wikidata":"https://www.wikidata.org/wiki/Q7268788","display_name":"Quality of life (healthcare)","level":2,"score":0.2766000032424927},{"id":"https://openalex.org/C2776557347","wikidata":"https://www.wikidata.org/wiki/Q37187","display_name":"Red blood cell","level":2,"score":0.2705000042915344},{"id":"https://openalex.org/C500440147","wikidata":"https://www.wikidata.org/wiki/Q701216","display_name":"Pharmacotherapy","level":2,"score":0.2653000056743622},{"id":"https://openalex.org/C2777396833","wikidata":"https://www.wikidata.org/wiki/Q886722","display_name":"Blood product","level":2,"score":0.2578999996185303},{"id":"https://openalex.org/C2780664029","wikidata":"https://www.wikidata.org/wiki/Q5282120","display_name":"Disease burden","level":3,"score":0.25780001282691956},{"id":"https://openalex.org/C205545832","wikidata":"https://www.wikidata.org/wiki/Q17156455","display_name":"Young adult","level":2,"score":0.25040000677108765}],"mesh":[],"locations_count":1,"locations":[{"id":"pmh:oai:ajol.info:article/270554","doi":null,"is_oa":false,"landing_page_url":"https://www.ajol.info/index.php/jophas/article/download/270554/255357","pdf_url":null,"source":{"id":"https://openalex.org/S2764417862","display_name":"Journal of Pharmaceutical and Allied Sciences","issn_l":"1596-8499","issn":["1596-8499"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310321518","host_organization_name":"African Journals OnLine","host_organization_lineage":["https://openalex.org/P4310321518"],"host_organization_lineage_names":["African Journals OnLine"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"1596-8499","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4313248647","https://openalex.org/W7092552095","https://openalex.org/W7105507839","https://openalex.org/W1553559411","https://openalex.org/W4413742961","https://openalex.org/W2980799643","https://openalex.org/W4398240183","https://openalex.org/W2996219761","https://openalex.org/W2286834725","https://openalex.org/W2411528379"],"abstract_inverted_index":{"Hydroxyurea":[0,48],"was":[1,69,92,126,200],"the":[2,15,30,50,72,77,107,112,116,154,192,206,210,222],"first":[3],"prophylactic":[4],"drug":[5],"used":[6],"for":[7,52],"sickle":[8,61,80,101,239],"cell":[9,36,62,81,102,240],"disease":[10,103,241],"management":[11,78],"because":[12],"it":[13],"lowers":[14],"frequency":[16,223],"and":[17,42,54,59,129,131,135,145,166,203,228,235],"severity":[18],"of":[19,66,74,79,97,111,115,118,153,174,178,205,212,224],"vaso-":[20],"occlusive":[21],"crises.":[22],"It":[23,214],"increases":[24],"hemoglobin":[25],"which":[26],"carries":[27],"oxygen":[28],"round":[29],"body":[31],"by":[32],"prolonging":[33],"red":[34],"blood":[35,46,55,189,229],"life":[37],"span,":[38],"hydration,":[39],"rheology":[40],"(of?)":[41],"normalizes":[43],"elevated":[44],"white":[45],"cells.":[47],"reduces":[49],"need":[51],"hospitalization":[53,227],"transfusion":[56,190,230],"in":[57,76,83,191,248],"children":[58],"adult":[60],"patients.":[63,233],"The":[64,124],"aim":[65],"this":[67,249],"study":[68,85,90],"to":[70,209],"evaluate":[71],"effectiveness":[73,211],"hydroxyurea":[75,105,181,220],"patients":[82,99,155,179,207,247],"a":[84,95],"population.":[86],"A":[87],"descriptive":[88],"cross-sectional":[89],"design":[91],"adopted":[93],"using":[94,137,180],"sample":[96],"59":[98],"with":[100,161,238],"receiving":[104],"at":[106],"Quality":[108],"Control":[109],"Unit":[110],"Pharmacy":[113],"Department":[114],"University":[117],"Benin":[119,122],"Teaching":[120],"Hospital,":[121],"City.":[123],"questionnaire":[125],"both":[127],"interviewer-":[128],"self-administered,":[130],"responses":[132],"were":[133,141,149,157,164,168],"entered":[134],"analyzed":[136],"Microsoft":[138],"Excel.":[139],"Results":[140],"represented":[142],"as":[143],"frequencies":[144],"percentages.":[146],"Ethical":[147],"considerations":[148],"observed.":[150],"About":[151,176],"81.4%":[152],"recruited":[156],"presently":[158],"being":[159],"treated":[160],"hydroxyurea,":[162],"45.8%":[163],"females":[165],"50%":[167],"within":[169],"5":[170],"\u2013":[171],"14":[172],"years":[173],"age.":[175],"67.9%":[177],"had":[182,187,242],"no":[183],"pain":[184,225],"crises,":[185,226],"83.0%":[186],"on":[188],"last":[193],"one":[194],"year.":[195],"Self-":[196],"reported":[197],"health":[198,250],"improvement":[199],"high":[201],"(75.5%)":[202],"90.6%":[204],"attested":[208],"hydroxyurea.":[213],"can":[215],"thus":[216],"be":[217],"concluded":[218],"that":[219],"reduced":[221,244],"among":[231,245],"SCD":[232,246],"Morbidity":[234],"mortality":[236],"associated":[237],"been":[243],"facility.":[251]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-10-05T00:00:00"}